Peripheral neuropathy and lifestyle factors in women with breast cancer receiving taxane-based chemotherapy: Pathway analysis

Basit Öğe Kaydı
dc.contributor.authorEllikci, Rabia
dc.contributor.authorArslan, Selda
dc.date.accessioned2024-02-23T14:02:45Z
dc.date.available2024-02-23T14:02:45Z
dc.date.issued2023
dc.departmentNEÜen_US
dc.description.abstractPurpose: Peripheral neuropathy adversely affects the treatment process of cancer, and thus it is important to reveal the factors leading to peripheral neuropathy and to take the necessary precautions to avoid it. This study was conducted to investigate the relationship between chemotherapy-induced peripheral neuropathy (CIPN) and lifestyle factors (nutrition, physical activity and sleep quality).Methods: This descriptive and correlational study was conducted with 108 individuals who were treated in the chemotherapy unit of a hospital between April 2021 and April 2022 in Turkey. Data were collected using the Chemotherapy-Induced Peripheral Neuropathy Assessment Tool (CIPNAT), the International Physical Activity Questionnaire (IPAQ), the Mini Nutritional Assessment Test (MNA), and the sleep level Visual Analog Scale. Number, percentages, means, and standard deviations were calculated, and multiple linear regression analysis and path analysis were conducted to analyze the data.Results: The results indicate that the total MET score significantly and positively predicted the sleep scale score (beta = 0.24, p < 0.01), while it negatively and significantly predicted the CIPNAT score (beta =-0.30, p < 0.001). In addition, both the MNA screening score and the sleep scale score significantly and negatively predicted the CIPNAT score (beta =-0.25, p < 0.01, beta =-0.29, p < 0.001, respectively).Conclusions: Lifestyle factors (exercise, nutrition, sleep) were found to have an effect on peripheral neuropathy. It is thought that increasing the level of exercise improves sleep quality, and regular nutrition, quality sleep and increased physical activity may be effective in reducing peripheral neuropathy.en_US
dc.identifier.doi10.1016/j.ejon.2023.102415
dc.identifier.issn1462-3889
dc.identifier.issn1532-2122
dc.identifier.pmid37769541en_US
dc.identifier.scopus2-s2.0-85172014531en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.urihttps://doi.org/10.1016/j.ejon.2023.102415
dc.identifier.urihttps://hdl.handle.net/20.500.12452/11834
dc.identifier.volume66en_US
dc.identifier.wosWOS:001085236900001en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevier Sci Ltden_US
dc.relation.ispartofEuropean Journal Of Oncology Nursingen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectChemotherapyen_US
dc.subjectLifestyle Factorsen_US
dc.subjectPeripheral Neuropathyen_US
dc.subjectNurseen_US
dc.titlePeripheral neuropathy and lifestyle factors in women with breast cancer receiving taxane-based chemotherapy: Pathway analysisen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu